2026. Antitumor Activity of New Methylpyrazolotriazine and Pyrazolobenzotriazine Derivatives Tested on MCF-7, MDA-MB-231, and BT-474 Breast Cancer Cell Lines. Voprosy onkologii. 72, 3 (Jul. 2026), OF-2446. DOI:https://doi.org/10.37469/0507-3758-2026-72-3-OF-2446.